SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-201850
Filing Date
2010-08-31
Accepted
2010-08-31 16:42:48
Documents
4
Period of Report
2010-08-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 20851
2 ENGLISH TRANSLATION OF PRESS RELEASE OF CELL THERAPEUTICS, INC dex991.htm EX-99.1 50229
3 GRAPHIC g17297g33i08.jpg GRAPHIC 4840
4 GRAPHIC g17297g68y50.jpg GRAPHIC 3130
  Complete submission text file 0001193125-10-201850.txt   83935
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 101050465
SIC: 2834 Pharmaceutical Preparations